These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 11191833

  • 1. Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor.
    Hashiba E, Harrison C, Galo' G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):28-33. PubMed ID: 11191833
    [Abstract] [Full Text] [Related]

  • 2. Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198 in Chinese hamster ovary cells expressing recombinant human nociceptin receptors.
    Hashiba E, Lambert DG, Jenck F, Wichmann J, Smith G.
    Life Sci; 2002 Mar 01; 70(15):1719-25. PubMed ID: 12002517
    [Abstract] [Full Text] [Related]

  • 3. Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor.
    Hashimoto Y, Caló G, Guerrini R, Smith G, Lambert DG.
    Neurosci Lett; 2000 Jan 07; 278(1-2):109-12. PubMed ID: 10643813
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B, Carrà G, Fantin M, Fischetti C, Hebbes C, McDonald J, Barnes TA, Rizzi A, Trapella C, Fanton G, Morari M, Lambert DG, Regoli D, Calò G.
    J Pharmacol Exp Ther; 2007 Jun 07; 321(3):961-7. PubMed ID: 17329552
    [Abstract] [Full Text] [Related]

  • 5. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
    Guerrini R, Caló G, Bigoni R, Rizzi A, Varani K, Toth G, Gessi S, Hashiba E, Hashimoto Y, Lambert DG, Borea PA, Tomatis R, Salvadori S, Regoli D.
    J Med Chem; 2000 Jul 27; 43(15):2805-13. PubMed ID: 10956188
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
    Okawa H, Nicol B, Bigoni R, Hirst RA, Calo G, Guerrini R, Rowbotham DJ, Smart D, McKnight AT, Lambert DG.
    Br J Pharmacol; 1999 May 27; 127(1):123-30. PubMed ID: 10369464
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M, Barnes TA, Carra G, McDonald J, Calo G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec 27; 368(6):528-37. PubMed ID: 14598020
    [Abstract] [Full Text] [Related]

  • 8. Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor.
    McDonald J, Barnes TA, Calo G, Guerrini R, Rowbotham DJ, Lambert DG.
    Eur J Pharmacol; 2002 May 17; 443(1-3):7-12. PubMed ID: 12044785
    [Abstract] [Full Text] [Related]

  • 9. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.
    Hashimoto Y, Calo' G, Guerrini R, Smith G, Lambert DG.
    Eur J Pharmacol; 2002 Aug 02; 449(1-2):17-22. PubMed ID: 12163101
    [Abstract] [Full Text] [Related]

  • 10. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2002 May 02; 136(2):303-11. PubMed ID: 12010780
    [Abstract] [Full Text] [Related]

  • 11. A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397.
    Ozaki S, Kawamoto H, Itoh Y, Miyaji M, Iwasawa Y, Ohta H.
    Eur J Pharmacol; 2000 Jan 17; 387(3):R17-8. PubMed ID: 10650183
    [Abstract] [Full Text] [Related]

  • 12. [3H]ac-RYYRWK-NH2, a novel specific radioligand for the nociceptin/orphanin FQ receptor.
    Thomsen C, Valsborg JS, Platou J, Martin J, Foged C, Johansen NL, Olsen UB, Madsen K.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec 17; 362(6):538-45. PubMed ID: 11138846
    [Abstract] [Full Text] [Related]

  • 13. Effects of nociceptinNH2 and [Nphe1]nociceptin(1-13)NH2 on rat brain noradrenaline release in vivo and in vitro.
    Okawa H, Kudo M, Kudo T, Guerrini R, Lambert DG, Kushikata T, Yoshida H, Matsuki A.
    Neurosci Lett; 2001 May 11; 303(3):173-6. PubMed ID: 11323113
    [Abstract] [Full Text] [Related]

  • 14. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.
    Bigoni R, Rizzi A, Rizzi D, Becker JA, Kieffer BL, Simonin F, Regoli D, Calo G.
    Life Sci; 2000 Dec 01; 68(2):233-9. PubMed ID: 11191640
    [Abstract] [Full Text] [Related]

  • 15. Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and µ-opioid receptor agonism.
    Schiene K, Tzschentke TM, Schröder W, Christoph T.
    Eur J Pharmacol; 2015 May 05; 754():61-5. PubMed ID: 25697471
    [Abstract] [Full Text] [Related]

  • 16. In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist.
    Bigoni R, Calo' G, Rizzi A, Guerrini R, De Risi C, Hashimoto Y, Hashiba E, Lambert DG, Regoli D.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May 05; 361(5):565-8. PubMed ID: 10832612
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.
    Ozaki S, Kawamoto H, Itoh Y, Miyaji M, Azuma T, Ichikawa D, Nambu H, Iguchi T, Iwasawa Y, Ohta H.
    Eur J Pharmacol; 2000 Aug 18; 402(1-2):45-53. PubMed ID: 10940356
    [Abstract] [Full Text] [Related]

  • 18. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.
    Rizzi D, Bigoni R, Rizzi A, Jenck F, Wichmann J, Guerrini R, Regoli D, Calo G.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 May 18; 363(5):551-5. PubMed ID: 11383716
    [Abstract] [Full Text] [Related]

  • 19. The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1-13)NH2, potentiates morphine analgesia.
    Rizzi A, Bigoni R, Marzola G, Guerrini R, Salvadori S, Regoli D, Calo G.
    Neuroreport; 2000 Aug 03; 11(11):2369-72. PubMed ID: 10943687
    [Abstract] [Full Text] [Related]

  • 20. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.
    Wright KE, McDonald J, Barnes TA, Rowbotham DJ, Guerrini R, Calo' G, Lambert DG.
    Neurosci Lett; 2003 Aug 07; 346(3):145-8. PubMed ID: 12853105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.